Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Plos One|February 26, 2008
A new perspective on transcriptional system regulation (TSR): towards TSR profilingRudolf S N Fehrmann, Hendrik J M de Jonge, Arja Ter Elst, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2015
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian CancerMaartje C A Wouters, Fenne L Komdeur, Hagma H Workel, et al.
Nature Communications|November 25, 2025
WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress responseRinskje B Tjeerdsma, Timothy F Ng, Maurits Roorda, et al.
Psychology and Psychotherapy|August 2, 2023
Investigating the relationship between negative symptoms and metacognitive functioning in psychosis: An individual participant data meta-analysisNicola McGuire, Andrew Gumley, Ilanit Hasson-Ohayon, et al.
Psychology and Psychotherapy|October 21, 2023
Investigating the relationship between specific negative symptoms and metacognitive functioning in psychosis: A systematic reviewNicola McGuire, Andrew Gumley, Ilanit Hasson-Ohayon, et al.
European Journal of Heart Failure|December 21, 2010
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of CardiologyThomas Eschenhagen, Thomas Force, Michael S Ewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell CarcinomaJoseph J Caumanns, Katrien Berns, G Bea A Wisman, et al.
Nature Reviews. Cancer|September 16, 2017
Interrogating open issues in cancer medicine with patient-derived xenograftsAnnette T Byrne, Denis G Alférez, Frédéric Amant, et al.
Pageof 14